机构

• 上海药物研究所 [19]

采集方式

• OAI收割 [19]

内容类型

• 期刊论文 [19]

发表日期

• 2022 [1]
• 2021 [2]
• 2019 [2]
• 2017 [1]
• 2016 [4]
• 2015 [1]
• 更多

学科主题

• Chemistry [2]
• Pharmacolo... [2]
• Biochemist... [1]

筛选

浏览/检索结果: 共19条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Dual-targeting prodrug nanotheranostics for NIR-II fluorescence imaging-guided photo-immunotherapy of glioblastoma 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3486-3497 作者:  Li, Fenglin;  Lai, Yi;  Ye, Jiayi;  Saeed, Madiha;  Dang, Yijing   |  收藏  |  浏览/下载：28/0  |  提交时间：2022/12/13 Glioblastoma  Dual targeting  Photothermal therapy  NIR-II fluorescence imaging  Precise immunotherapy   Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2 期刊论文  OAI收割 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 卷号: 118, 期号: 32, 页码: 8 作者:     |  收藏  |  浏览/下载：54/0  |  提交时间：2021/11/04 parathyroid hormone receptor 2  cryo-electron microscopy  G protein-coupled receptor  ligand recognition  syndromic short stature   Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2021, 卷号: 12, 期号: 1, 页码: 11 作者:  Cong, Zhaotong;  Chen, Li-Nan;  Ma, Honglei;  Zhou, Qingtong;  Zou, Xinyu   |  收藏  |  浏览/下载：60/0  |  提交时间：2021/08/17 Lycodine-type alkaloids from Lycopodiastrum casuarinoides and their acetylcholinesterase inhibitory activity 期刊论文  OAI收割 FITOTERAPIA, 2019, 卷号: 139, 页码: 7 作者:  Feng, Zheling;  Chen, Shixin;  Wang, Wei;  Feng, Lu;  Dong, Yanyan   |  收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01 Lycopodiastrum casuarinoides  Lycopodiaceae  Lycodine-type alkaloids  TD-DFT  ECD   Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses 期刊论文  OAI收割 CELL DISCOVERY, 2019, 卷号: 5, 页码: 15 作者:  Chen, Jinhuan;  Ye, Xiaohua;  Zhang, Xue-Yang;  Zhu, Zhengdan;  Zhang, Xiang   |  收藏  |  浏览/下载：26/0  |  提交时间：2020/07/01 Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 2, 页码: 157-167 作者:  Zou, Kun;  Li, Zhao;  Zhang, Yong;  Zhang, Hao-yue;  Li, Bo   |  收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08 berberine  natural product  anti-inflammatory drug  anticancer drug  digestive system  structure-activity relationship   OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 10, 页码: 1359-1369 作者:  Ma, Shan-yao;  Ning, Meng-meng;  Zou, Qing-an;  Feng, Ying;  Ye, Yang-liang   |  收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 OL3  MN6  linagliptin  TGR5 agonist  DPP4 inhibitor  GLP-1  low-absorbed  gallbladder filling  type 2 diabetes mellitus   Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect 期刊论文  OAI收割 SCIENTIFIC REPORTS, 2016, 卷号: 6 作者:  Cao, Hua;  Chen, Zhi-Xiang;  Wang, Kai;  Ning, Meng-Meng;  Zou, Qing-An   |  收藏  |  浏览/下载：12/0  |  提交时间：2019/01/08 Discovery and Structure-Activity Relationship Study of 4-Phenoxythiazol-5-carboxamides as Highly Potent TGR5 Agonists 期刊论文  OAI收割 CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 卷号: 64, 期号: 4, 页码: 326-339 作者:  Chen, Zhixiang;  Ning, Mengmeng;  Zou, Qingan;  Cao, Hua;  Ye, Yangliang   |  收藏  |  浏览/下载：9/0  |  提交时间：2019/01/08 Takeda G-protein-coupled receptor 5 agonist  bioisostere  microsomal clearance  structure-activity relationship   ol3anovellowabsorbedtgr5agonistwithreducedsideeffectsloweredbloodglucoseviadualactionsontgr5activationanddpp4inhibition 期刊论文  OAI收割 actapharmacologicasinica, 2016, 卷号: 000, 期号: 010, 页码: 1359 作者:  Ma Shanyao;  Ning Mengmeng;  Zou Qingan;  Feng Ying;  Ye Yangliang   |  收藏  |  浏览/下载：11/0  |  提交时间：2020/07/01 OL3  MN6  linagliptin  TGR5 agonist  DPP4 inhibitor  GLP-1  low-absorbed  gallbladder filling  type 2 diabetes mellitus